Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Strata Critical Medical's EPS for the twelve months ending Jun 30, 2026 was $0.51. For fiscal 2025 it was $0.50. The highest annual figure on record is $0.50 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.50 | – |
| FY2024 | Dec 31, 2024 | -$0.35 | – |
| FY2023 | Dec 31, 2023 | -$0.76 | – |
| FY2021 | Sep 30, 2021 | -$0.93 | – |
| FY2020 | Sep 30, 2020 | -$0.40 | – |
| FY2019 | Sep 30, 2019 | -$0.43 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$0.12 | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $0.03 | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$0.10 | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $0.70 | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$0.05 | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$0.04 | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$0.12 | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$0.03 | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$0.15 | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$0.06 | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$0.45 | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $0.00 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$0.17 | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$0.14 | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$0.13 | – |
| Q2 FY2020CQ1 2020 | Jun 30, 2020 | -$0.05 | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$0.01 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?